Risk factor
Vulnerable to price shocks
Profitability factor
Very weak growth
About
Takara Bio Inc., together with its subsidiaries, operates as a biotechnology company in Japan, the United States, China, other Asia, Europe, and internationally. The company operates through Bioindustry and Gene Therapy segments. It develops research reagents and scientific instruments; and provides contract development and manufacturing organization (CDMO) services for academic and corporate life sciences research...
Company Valuation
Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. In particular, the stock is overpriced on P/E, 'cheap' on EV/EBITDA, ov
Target Price
The average target price of 4974.T is 1234 and suggests 54% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr
Buy
Sell